Leicestershire, United Kingdom

Ian Millichip

USPTO Granted Patents = 5 



Average Co-Inventor Count = 5.9

ph-index = 2

Forward Citations = 22(Granted Patents)


Location History:

  • Loughborough, GB (2005 - 2012)
  • Leicestershire, GB (2012 - 2015)

Company Filing History:


Years Active: 2005-2015

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Ian Millichip: Innovator in Immunomodulating Compounds

Introduction

Ian Millichip is a notable inventor based in Leicestershire, GB. He has made significant contributions to the field of immunomodulating compounds, holding a total of 5 patents. His work focuses on developing compounds that have potential applications as antiviral and antiallergic agents.

Latest Patents

Millichip's latest patents include a 9-substituted 8-oxoadenine compound. This invention provides an 8-oxoadenine compound that exhibits immunomodulating activities, such as interferon inducing activity. It is useful as an antiviral agent and antiallergic agent. The compound is represented by a specific formula that includes various chemical components, such as aromatic carbocyclic rings and halogen atoms.

Career Highlights

Throughout his career, Ian Millichip has worked with prominent companies, including AstraZeneca AB and AstraZeneca Aktiebolag. His experience in these organizations has contributed to his expertise in the development of innovative pharmaceutical compounds.

Collaborations

Millichip has collaborated with notable colleagues, including Stephen Brough and Roger Victor Bonnert. These collaborations have likely enhanced his research and development efforts in the field of immunomodulating compounds.

Conclusion

Ian Millichip's contributions to the field of immunomodulating compounds highlight his innovative spirit and dedication to advancing medical science. His patents reflect a commitment to developing effective antiviral and antiallergic agents that can benefit society.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…